TC BioPharm targets AML relapse with innovative gamma-delta T cell therapy
Investing.com - 10-Feb-2025TC BioPharm’s Phase 2B trial shows TCB008 is safe with promising early effects in AML
Leukemia
Leukemia News
Therapeutic applications of base editing clears girl's leukemia
BBC - 11-Dec-2022Base editing can soon be a part in taking control of our genomes to fight genetic diseases
Leukemia Resources
No resources found!
Leukemia Blog Posts
No blog posts found!
